Details for Patent: 7,786,158

Which drugs does patent 7,786,158 protect, and when does it expire?

Patent 7,786,158 protects VIBERZI and is included in one NDA.

This patent has eighty-three patent family members in thirty-five countries.

Summary for Patent: 7,786,158

Title:	Compounds as opioid receptor modulators
Abstract:	The present invention is directed to novel opioid receptor modulators of Formula (I). ##STR00001## The invention further relates to methods for preparing such compounds, pharmaceutical compositions containing them, and their use in the treatment of disorders that may be ameliorated or treated by the modulation of opioid receptors.
Inventor(s):	Breslin; Henry J. (Lansdale, PA), Cai; Chaozhong (N. Wales, PA), He; Wei (Audobon, PA), Kavash; Robert W. (Glenside, PA)
Assignee:	Janssen Pharmaceutica N.V. (Beerse, BE)
Application Number:	11/877,747
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,786,158
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 7,786,158

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Abbvie	VIBERZI	eluxadoline	TABLET;ORAL	206940-001	May 27, 2015		RX	Yes	No				Y
Abbvie	VIBERZI	eluxadoline	TABLET;ORAL	206940-002	May 27, 2015		RX	Yes	Yes				Y

International Family Members for US Patent 7,786,158

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	048269
Argentina	095848
Austria	E516274